Silence Therapeutics plc (SLNCF)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of 1.14M GBP in the quarter ending September 30, 2024, a decrease of -59.19%. This brings the company's revenue in the last twelve months to 16.25M, down -42.07% year-over-year. In the year 2023, Silence Therapeutics had annual revenue of 25.38M with 44.99% growth.

• Revenue (ttm): 16.25M GBP
• Revenue Growth: -42.07%
• P/S Ratio: n/a
• Revenue / Employee: 149.04K GBP
• Employees: 109
• Market Cap: 335.23M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	25.38M	7.87M	44.99%
Dec 31, 2022	17.50M	5.09M	40.97%
Dec 31, 2021	12.42M	6.94M	126.59%
Dec 31, 2020	5.48M	5.24M	2,145.49%
Dec 31, 2019	244.00K	-	-